18 items found

Tags: Biotechnology reimbursement

Filter Results
  • dataset

    Laws/regulations involving reimbursement for injury-induced medical expense i...

    Laws/regulations involving reimbursement for injury-induced medical expense in Chinese social medical insurance schemes.
  • dataset

    OR and 95% CI for reimbursement.

    OR and 95% CI for reimbursement.
  • dataset

    Comparison of OOP proportion between 2008 and 2011.

    Comparison of OOP proportion between 2008 and 2011.
  • dataset

    IC, IE & ICERs for the base case scenario (GOG-0218 (st.IV), ICON7 (high risk...

    IC, IE & ICERs for the base case scenario (GOG-0218 (st.IV), ICON7 (high risk), OCEANS, and AURELIA).
  • dataset

    Mean treatment duration and bevacizumab treatment costs.

    Mean treatment duration and bevacizumab treatment costs.
  • dataset

    QoL values.

    QoL values.
  • dataset

    Legislative documents concerning social medical insurance reimbursement of in...

    Legislative documents concerning social medical insurance reimbursement of injury-induced medical expenses, number (percentage).
  • dataset

    r37980778c78--3355a019144f49eeb528f8fcc8d934a5

    Efficacy analysis.
  • dataset

    Reimbursement for injury-induced medical expense in Chinese social medical in...

    Reimbursement for injury-induced medical expense in Chinese social medical insurance laws/regulations, number (percentage).
  • dataset

    Average proportion of CHE before and after NCMS reimbursement policies.

    Average proportion of CHE before and after NCMS reimbursement policies.
  • dataset

    r37980778c78--fdd7955aaaa3cb29dbd1bbf86600fab3

    OR and 95% CI for maternal services utilization.
  • dataset

    r37980778c78--a63e6918d0f2fcf0c0c39fb14005a724

    BackgroundThe New Rural Cooperative Medical Scheme (NCMS) includes a maternal care benefits package that is associated with increasing maternal health services. The local...
  • dataset

    r37980778c78--ef3a8361301b9d9cc78297836a07f41e

    Subgroup comparison data.
  • dataset

    r37980778c78--a0d8164232c266baf962d26efa98a8dd

    Demographic and disease characteristics of the study population.
  • dataset

    r37980778c78--9204f1ba0aeb1cfe5c742fda76a6327c

    Eligible patient population and bevacizumab treatment schedules in 4 peer-reviewed RCTs.
  • dataset

    First- and second-line bevacizumab in ovarian cancer: A Belgian cost-utility ...

    BackgroundCurrently, in Belgium, bevacizumab is reimbursed for ovarian cancer patients, based on a contract between the Minister and the manufacturer including confidential...
  • dataset

    Reimbursement for medical expenses caused by injuries having no responsible p...

    Reimbursement for medical expenses caused by injuries having no responsible person/party and not caused by given reasons in Chinese legislative documents (number/proportion).
  • dataset

    Differences in OOP proportion between 2008 and 2011 by covariance analyses.

    Differences in OOP proportion between 2008 and 2011 by covariance analyses.